Literature DB >> 25001299

Frequency of outpatient antibiotic prescription on discharge to hospice care.

Jon P Furuno1, Brie N Noble2, Kristi N Horne3, Jessina C McGregor2, Miriam R Elman2, David T Bearden2, Eric W Walsh4, Erik K Fromme5.   

Abstract

The use of antibiotics is common in hospice care despite limited evidence that it improves symptoms or quality of life. Patients receiving antibiotics upon discharge from a hospital may be more likely to continue use following transition to hospice care despite a shift in the goals of care. We quantified the frequency and characteristics for receiving a prescription for antibiotics on discharge from acute care to hospice care. This was a cross-sectional study among adult inpatients (≥18 years old) discharged to hospice care from Oregon Health & Science University (OHSU) from 1 January 2010 to 31 December 2012. Data were collected from an electronic data repository and from the Department of Care Management. Among 62,792 discharges, 845 (1.3%) patients were discharged directly to hospice care (60.0% home and 40.0% inpatient). Most patients discharged to hospice were >65 years old (50.9%) and male (54.6%) and had stayed in the hospital for ≤7 days (56.6%). The prevalence of antibiotic prescription upon discharge to hospice was 21.1%. Among patients discharged with an antibiotic prescription, 70.8% had a documented infection during their index admission. Among documented infections, 40.3% were bloodstream infections, septicemia, or endocarditis, and 38.9% were pneumonia. Independent risk factors for receiving an antibiotic prescription were documented infection during the index admission (adjusted odds ratio [AOR]=7.00; 95% confidence interval [95% CI]=4.68 to 10.46), discharge to home hospice care (AOR=2.86; 95% CI=1.92 to 4.28), and having a cancer diagnosis (AOR=2.19; 95% CI=1.48 to 3.23). These data suggest that a high proportion of patients discharged from acute care to hospice care receive an antibiotic prescription upon discharge.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25001299      PMCID: PMC4135830          DOI: 10.1128/AAC.02873-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).

Authors: 
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04       Impact factor: 3.254

2.  Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients.

Authors:  Paul J Ford; Thomas G Fraser; Mellar P Davis; Eric Kodish
Journal:  Bioethics       Date:  2005-08       Impact factor: 1.898

3.  Cost and utilization outcomes of patients receiving hospital-based palliative care consultation.

Authors:  Joan D Penrod; Partha Deb; Carol Luhrs; Cornelia Dellenbaugh; Carolyn W Zhu; Tsivia Hochman; Matthew L Maciejewski; Evelyn Granieri; R Sean Morrison
Journal:  J Palliat Med       Date:  2006-08       Impact factor: 2.947

4.  Incorporating routine survival prediction in a U.S. hospital-based palliative care service.

Authors:  Erik K Fromme; Mary Denise Smith; Paul B Bascom; Tawni Kenworthy-Heinige; Karen S Lyons; Susan W Tolle
Journal:  J Palliat Med       Date:  2010-12-03       Impact factor: 2.947

5.  Bacterial infections in terminally ill hospice patients.

Authors:  L Vitetta; D Kenner; A Sali
Journal:  J Pain Symptom Manage       Date:  2000-11       Impact factor: 3.612

6.  Palliative care consultation teams cut hospital costs for Medicaid beneficiaries.

Authors:  R Sean Morrison; Jessica Dietrich; Susan Ladwig; Timothy Quill; Joseph Sacco; John Tangeman; Diane E Meier
Journal:  Health Aff (Millwood)       Date:  2011-03       Impact factor: 6.301

7.  The consistency between treatments provided to nursing facility residents and orders on the physician orders for life-sustaining treatment form.

Authors:  Susan E Hickman; Christine A Nelson; Alvin H Moss; Susan W Tolle; Nancy A Perrin; Bernard J Hammes
Journal:  J Am Geriatr Soc       Date:  2011-10-22       Impact factor: 5.562

8.  Causes of death at autopsy in an inpatient hospice program.

Authors:  Isam A Abdel-Karim; Robert B Sammel; Mark A Prange
Journal:  J Palliat Med       Date:  2007-08       Impact factor: 2.947

9.  Association between Physician Orders for Life-Sustaining Treatment for Scope of Treatment and in-hospital death in Oregon.

Authors:  Erik K Fromme; Dana Zive; Terri A Schmidt; Jennifer N B Cook; Susan W Tolle
Journal:  J Am Geriatr Soc       Date:  2014-06-09       Impact factor: 5.562

10.  Cost savings associated with US hospital palliative care consultation programs.

Authors:  R Sean Morrison; Joan D Penrod; J Brian Cassel; Melissa Caust-Ellenbogen; Ann Litke; Lynn Spragens; Diane E Meier
Journal:  Arch Intern Med       Date:  2008-09-08
View more
  8 in total

1.  Antimicrobials at the End of Life: An Opportunity to Improve Palliative Care and Infection Management.

Authors:  Manisha Juthani-Mehta; Preeti N Malani; Susan L Mitchell
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

2.  Antimicrobial Use in Patients on a Comfort Care Protocol: A Retrospective Cohort Study.

Authors:  Susan E Merel; Cynthia A Meier; Christy M McKinney; Paul S Pottinger
Journal:  J Palliat Med       Date:  2016-06-16       Impact factor: 2.947

3.  Prevalence and Clinical Intentions of Antithrombotic Therapy on Discharge to Hospice Care.

Authors:  Christina A Kowalewska; Brie N Noble; Erik K Fromme; Mary Lynn McPherson; Kristi N Grace; Jon P Furuno
Journal:  J Palliat Med       Date:  2017-06-05       Impact factor: 2.947

4.  Association of Physician Orders for Life-Sustaining Treatment With Inpatient Antimicrobial Use at End of Life in Patients With Cancer.

Authors:  Olivia S Kates; Elizabeth M Krantz; Juhye Lee; John Klaassen; Jessica Morris; Irina Mezheritsky; Ania Sweet; Frank Tverdek; Elizabeth T Loggers; Steven A Pergam; Catherine Liu
Journal:  Open Forum Infect Dis       Date:  2021-08-02       Impact factor: 4.423

Review 5.  Implementing Antimicrobial Stewardship in Long-term Care Settings: An Integrative Review Using a Human Factors Approach.

Authors:  Morgan J Katz; Ayse P Gurses; Pranita D Tamma; Sara E Cosgrove; Melissa A Miller; Robin L P Jump
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

6.  Clinical Intentions of Antibiotics Prescribed Upon Discharge to Hospice Care.

Authors:  Sarah A Servid; Brie N Noble; Erik K Fromme; Jon P Furuno
Journal:  J Am Geriatr Soc       Date:  2018-01-18       Impact factor: 5.562

7.  Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia.

Authors:  Nathan M Stall; Hadas D Fischer; Kinwah Fung; Vasily Giannakeas; Susan E Bronskill; Peter C Austin; Jeremy N Matlow; Kieran L Quinn; Susan L Mitchell; Chaim M Bell; Paula A Rochon
Journal:  JAMA Netw Open       Date:  2019-08-02

8.  Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections.

Authors:  Jon P Furuno; Gregory B Tallman; Brie N Noble; Joseph S Bubalo; Graeme N Forrest; James S Lewis; Ana F Bienvenida; Courtney A Holmes; Bo R Weber; Jessina C McGregor
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.